Compare · LIVN vs TIVC
LIVN vs TIVC
Side-by-side comparison of LivaNova PLC (LIVN) and Tivic Health Systems Inc. (TIVC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both LIVN and TIVC operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
- LIVN is the larger of the two at $4.36B, about 1082.4x TIVC ($4.0M).
- Over the past year, LIVN is up 73.6% and TIVC is down 63.6% - LIVN leads by 137.1 points.
- LIVN has been more active in the news (8 items in the past 4 weeks vs 4 for TIVC).
- LIVN has more recent analyst coverage (20 ratings vs 0 for TIVC).
- Company
- LivaNova PLC
- Tivic Health Systems Inc.
- Price
- $79.40-0.66%
- $1.40+4.49%
- Market cap
- $4.36B
- $4.0M
- 1M return
- +9.65%
- +39.50%
- 1Y return
- +73.55%
- -63.58%
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- News (4w)
- 8
- 4
- Recent ratings
- 20
- 0
LivaNova PLC
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates in two segments, Cardiovascular (CV) and Neuromodulation (NM). The CV segment develops, produces, and sells cardiopulmonary products, including heart-lung machines, oxygenators, perfusion tubing sets, cannulae, and accessories, as well as related equipment and disposables for autotransfusion and autologous blood washing for neonatal, pediatric, and adult patients. It also provides surgical tissue and mechanical valve replacements, and repair products for damaged or diseased heart valves, such as self-anchoring tissue heart, tissue heart, and mechanical heart valves, as well as heart valve repair products; and temporary extracorporeal cardiopulmonary life support solutions for critically ill patients. The NM segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. It sells its products through direct sales representatives and independent distributors. The company has a research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom.
Tivic Health Systems Inc.
Tivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. The company's primary product, ClearUP, is a medical device intended to relieve sinus and nasal inflammation. It sells its products on direct-to-consumer channel through its own websites and platforms, such as Amazon.com, as well as to major U.S. online retailers, such as BestBuy.com, FSAStore.com, Walgreens.com, Walmart.com. The company was incorporated in 2016 and is headquartered in Newark, California.
Latest LIVN
- Jette Nygaard-Andersen Joins LivaNova Board as a New Director
- New insider Nygaard-Andersen Jette claimed no ownership of stock in the company (SEC Form 3)
- LivaNova PLC filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- LivaNova Appoints Anne Liddy as Chief Legal Officer
- SEC Form SD filed by LivaNova PLC
- Director Bianchi Francesco sold $136,350 worth of Ordinary Shares (1,800 units at $75.75), decreasing direct ownership by 20% to 7,228 units (SEC Form 4)
- LivaNova Appoints Stefano Folli to Lead its Cardiopulmonary Business Unit
- LivaNova to Present at Goldman Sachs Global Healthcare Conference in June
- SEC Form IRANNOTICE filed by LivaNova PLC
- SEC Form 10-Q filed by LivaNova PLC
Latest TIVC
- SEC Form S-8 filed by Tivic Health Systems Inc.
- SEC Form S-8 filed by Tivic Health Systems Inc.
- Tivic Health Systems Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Chief Executive Officer Handley Michael K converted options into 2,206 shares, increasing direct ownership by 25% to 11,030 units (SEC Form 4)
- SEC Form 10-Q filed by Tivic Health Systems Inc.
- Tivic Health Systems Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form 4 filed by General Counsel & SVP of Legal Lackey Melinda
- SEC Form 3 filed by new insider Lackey Melinda
- Tivic Health Systems Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form DEF 14A filed by Tivic Health Systems Inc.